Patents by Inventor Paul F. Glidden

Paul F. Glidden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONTROLLED RELEASE COMPOSITIONS OF AGENTS THAT REDUCE CIRCULATING LEVELS OF PLATELETS AND METHODS THEREFOR
    Publication number: 20180153810
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Application
    Filed: July 12, 2017
    Publication date: June 7, 2018
    Inventors: Paul F. GLIDDEN, Alison J. PILGRIM, Stephen R. HANSON
  • Cellular activity targeted nanoparticle system and methods of producing the nanoparticle system
    Patent number: 9962443
    Abstract: Embodiments of nanoparticle systems and methods of producing nanoparticle systems configured to target particular cellular activity in an animal or human including a signaling pathway expression of mammal cellular activity and treat cells producing the targeted cellular activity by exposing the nanoparticle system to electromagnetic radiation in a predetermined range of wavelengths. Other embodiments may be described and claimed.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: May 8, 2018
    Inventors: Paul F. Glidden, Steven Oldenburg
  • Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
    Patent number: 9750698
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: September 5, 2017
    Assignee: BioVascular, Inc.
    Inventors: Paul F. Glidden, Alison J. Pilgrim, Stephen R. Hanson
  • CONTROLLED RELEASE COMPOSITIONS OF AGENTS THAT REDUCE CIRCULATING LEVELS OF PLATELETS AND METHODS THEREFOR
    Publication number: 20170112767
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Application
    Filed: May 31, 2016
    Publication date: April 27, 2017
    Inventors: Paul F. GLIDDEN, Alison J. PILGRIM, Stephen R. HANSON
  • CELLULAR ACTIVITY TARGETED NANOPARTICLE SYSTEM AND METHODS OF PRODUCING THE NANOPARTICLE SYSTEM
    Publication number: 20170072055
    Abstract: Embodiments of nanoparticle systems and methods of producing nanoparticle systems configured to target particular cellular activity in an animal or human including a signaling pathway expression of mammal cellular activity and treat cells producing the targeted cellular activity by exposing the nanoparticle system to electromagnetic radiation in a predetermined range of wavelengths. Other embodiments may be described and claimed.
    Type: Application
    Filed: September 16, 2016
    Publication date: March 16, 2017
    Inventors: Paul F. Glidden, Steven Oldenburg
  • Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
    Patent number: 9381198
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: July 5, 2016
    Assignee: BioVascular, Inc.
    Inventors: Paul F. Glidden, Alison J. Pilgrim, Stephen R. Hanson
  • CONTROLLED RELEASE COMPOSITIONS OF AGENTS THAT REDUCE CIRCULATING LEVELS OF PLATELETS AND METHODS THEREFOR
    Publication number: 20160051552
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Application
    Filed: March 27, 2015
    Publication date: February 25, 2016
    Inventors: Paul F. GLIDDEN, Alison J. PILGRIM, Stephen R. HANSON
  • Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
    Patent number: 9040483
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Grant
    Filed: July 17, 2012
    Date of Patent: May 26, 2015
    Assignee: BIOVASCULAR, INC.
    Inventors: Paul F. Glidden, Alison J. Pilgrim, Stephen R. Hanson
  • CONTROLLED RELEASE COMPOSITIONS OF AGENTS THAT REDUCE CIRCULATING LEVELS OF PLATELETS AND METHODS THEREFOR
    Publication number: 20130022671
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Application
    Filed: July 17, 2012
    Publication date: January 24, 2013
    Inventors: Paul F. Glidden, Alison J. Pilgrim, Stephen R. Hanson
  • Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
    Patent number: 8188034
    Abstract: The present invention provides compositions of saratin and methods of use thereof. One aspect of the invention is a method of prevention or mitigation of the development of adhesions, keloids and scars. The adhesions, keloids and scars can be due to surgery, such as plastic surgery or orthopedic surgery, or can be pre-existing scars. Another aspect of the invention is a method for treatment of flexor tendon injuries.
    Type: Grant
    Filed: November 24, 2009
    Date of Patent: May 29, 2012
    Assignee: Biovascular, Inc.
    Inventor: Paul F. Glidden
  • Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
    Publication number: 20110034396
    Abstract: The present disclosure provides methods of use of saratin, including the prevention or mitigation of the development of adhesions, keloids and scars. The adhesions, keloids and scars can be due to surgery, such as plastic surgery or orthopedic surgery, or can be pre-existing scars. Adhesion, keloid and/or scar formation may also be prevented in surgical procedures utilizing shunts, implants or drainage devices, including surgical procedures to treat glaucoma.
    Type: Application
    Filed: August 27, 2010
    Publication date: February 10, 2011
    Applicant: BioVascular, Inc.
    Inventor: Paul F. Glidden
  • METHODS AND COMPOSITIONS FOR BLOCKING PLATELET AND CELL ADHESION, CELL MIGRATION AND INFLAMMATION
    Publication number: 20100129419
    Abstract: The present invention provides compositions of saratin and methods of use thereof. One aspect of the invention is a method of prevention or mitigation of the development of adhesions, keloids and scars. The adhesions, keloids and scars can be due to surgery, such as plastic surgery or orthopedic surgery, or can be pre-existing scars. Another aspect of the invention is a method for treatment of flexor tendon injuries.
    Type: Application
    Filed: November 24, 2009
    Publication date: May 27, 2010
    Inventor: Paul F. Glidden
  • Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
    Patent number: 7691839
    Abstract: The present invention provides compositions of saratin and methods of use thereof. One aspect of the invention is a method of prevention or mitigation of the development of adhesions, keloids and scars. The adhesions, keloids and scars can be due to surgery, such as plastic surgery or orthopedic surgery, or can be pre-existing scars. Another aspect of the invention is a method for treatment of flexor tendon injuries.
    Type: Grant
    Filed: September 28, 2006
    Date of Patent: April 6, 2010
    Assignee: Biovascular, Inc.
    Inventor: Paul F. Glidden
  • Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
    Publication number: 20090324710
    Abstract: Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
    Type: Application
    Filed: June 16, 2009
    Publication date: December 31, 2009
    Inventors: Paul F. Glidden, Alison J. Pilgrim, Stephen R. Hanson